Teriparatide
"Teriparatide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polypeptide that consists of the 1-34 amino-acid fragment of human PARATHYROID HORMONE, the biologically active N-terminal region. The acetate form is given by intravenous infusion in the differential diagnosis of HYPOPARATHYROIDISM and PSEUDOHYPOPARATHYROIDISM. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995)
| Descriptor ID |
D019379
|
| MeSH Number(s) |
D06.472.699.590.850 D12.644.548.587.850
|
| Concept/Terms |
Teriparatide- Teriparatide
- Human Parathyroid Hormone (1-34)
- hPTH (1-34)
Parathar- Parathar
- Aventis Brand of Teriparatide
- Teriparatide Aventis Brand
Forteo- Forteo
- Lilly Brand of Teriparatide
- Teriparatide Lilly Brand
|
Below are MeSH descriptors whose meaning is more general than "Teriparatide".
Below are MeSH descriptors whose meaning is more specific than "Teriparatide".
This graph shows the total number of publications written about "Teriparatide" by people in this website by year, and whether "Teriparatide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Teriparatide" by people in Profiles.
-
Liu W, Lee B, Nagamani SCS, Nicol L, Rauch F, Rush ET, Sutton VR, Orwoll E. Approach to the Patient: Pharmacological Therapies for Fracture Risk Reduction in Adults With Osteogenesis Imperfecta. J Clin Endocrinol Metab. 2023 06 16; 108(7):1787-1796.